Nexalin Technology, Inc. (NXL) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Nexalin Technology, Inc. on May 16, 2024. The Company is incorporated in Delaware and its common stock (NXL) and warrants (NXLIW) are listed on The Nasdaq Stock Market LLC. The filing addresses a regulatory notice regarding continued listing compliance.
Key Financial Metrics
The filing references the Company's most recent stockholders' equity position as reported in the Form 10-Q for the quarter ended March 31, 2024.
- Stockholders' Equity: $2,326,987
- Nasdaq Minimum Requirement: $2,500,000
The filing does not provide specific data regarding revenue, profit, cash flow, margins, or debt levels for the current period.
Material Changes and Listing Status
The Company received a letter from Nasdaq on May 16, 2024, notifying it of non-compliance with Nasdaq Listing Rule 5550(b)(1) due to stockholders' equity falling below the $2,500,000 threshold. As of the filing date, the Company's stock continues to trade on The Nasdaq Capital Market. There is no immediate delisting effect, but the Company must submit a Compliance Plan to regain standing.
Outlook, Risks, and Contingencies
Compliance Timeline: The Company has 45 calendar days (until July 1, 2024) to submit a Compliance Plan. If accepted, Nasdaq may grant an extension of up to 180 calendar days to evidence compliance.
Risks: The Company explicitly states there can be no assurance that it will be able to regain compliance with the Stockholders' Equity Requirement or other Nasdaq Listing Rules. Failure to comply could result in delisting.
Forward-Looking Statements: The report includes standard disclaimers regarding future events and financial performance, noting that actual results may differ materially from expectations due to various risks outlined in the Company's Form 10-K.
Investor Verification Checklist
- Verify the Company's submission of a Compliance Plan to Nasdaq by the July 1, 2024 deadline.
- Monitor the Company's stockholders' equity levels in subsequent filings to ensure they meet the $2,500,000 threshold.
- Review the Company's Form 10-K for the year ended December 31, 2023, for detailed risk factors.
- Confirm whether Nasdaq accepts the proposed Compliance Plan and grants the 180-day extension.